227 related articles for article (PubMed ID: 22589333)
1. A cellular response linking eIF4AI activity to eIF4AII transcription.
Galicia-Vázquez G; Cencic R; Robert F; Agenor AQ; Pelletier J
RNA; 2012 Jul; 18(7):1373-84. PubMed ID: 22589333
[TBL] [Abstract][Full Text] [Related]
2. Regulation of eukaryotic initiation factor 4AII by MyoD during murine myogenic cell differentiation.
Galicia-Vázquez G; Di Marco S; Lian XJ; Ma JF; Gallouzi IE; Pelletier J
PLoS One; 2014; 9(1):e87237. PubMed ID: 24466343
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs trigger dissociation of eIF4AI and eIF4AII from target mRNAs in humans.
Fukao A; Mishima Y; Takizawa N; Oka S; Imataka H; Pelletier J; Sonenberg N; Thoma C; Fujiwara T
Mol Cell; 2014 Oct; 56(1):79-89. PubMed ID: 25280105
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic translation initiation factor 4AIII (eIF4AIII) is functionally distinct from eIF4AI and eIF4AII.
Li Q; Imataka H; Morino S; Rogers GW; Richter-Cook NJ; Merrick WC; Sonenberg N
Mol Cell Biol; 1999 Nov; 19(11):7336-46. PubMed ID: 10523622
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of translation targeting eukaryotic translation initiation factor 4A.
Cencic R; Galicia-Vázquez G; Pelletier J
Methods Enzymol; 2012; 511():437-61. PubMed ID: 22713332
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot-and-mouth disease virus 3C protease: identification of the eIF4AI cleavage site.
Li W; Ross-Smith N; Proud CG; Belsham GJ
FEBS Lett; 2001 Oct; 507(1):1-5. PubMed ID: 11682048
[TBL] [Abstract][Full Text] [Related]
7. Single-molecule kinetics of the eukaryotic initiation factor 4AI upon RNA unwinding.
Sun Y; Atas E; Lindqvist LM; Sonenberg N; Pelletier J; Meller A
Structure; 2014 Jul; 22(7):941-8. PubMed ID: 24909782
[TBL] [Abstract][Full Text] [Related]
8. Targeting the N Terminus of eIF4AI for Inhibition of Its Catalytic Recycling.
Jiang C; Tang Y; Ding L; Tan R; Li X; Lu J; Jiang J; Cui Z; Tang Z; Li W; Cao Z; Schneider-Poetsch T; Jiang W; Luo C; Ding Y; Liu J; Dang Y
Cell Chem Biol; 2019 Oct; 26(10):1417-1426.e5. PubMed ID: 31402318
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic translation initiation factor 4AII contributes to microRNA-122 regulation of hepatitis C virus replication.
Ahmed CS; Winlow PL; Parsons AL; Jopling CL
Nucleic Acids Res; 2018 Jul; 46(12):6330-6343. PubMed ID: 29669014
[TBL] [Abstract][Full Text] [Related]
10. The eukaryotic initiation factor eIF4H facilitates loop-binding, repetitive RNA unwinding by the eIF4A DEAD-box helicase.
Sun Y; Atas E; Lindqvist L; Sonenberg N; Pelletier J; Meller A
Nucleic Acids Res; 2012 Jul; 40(13):6199-207. PubMed ID: 22457067
[TBL] [Abstract][Full Text] [Related]
11. Two related trypanosomatid eIF4G homologues have functional differences compatible with distinct roles during translation initiation.
Moura DM; Reis CR; Xavier CC; da Costa Lima TD; Lima RP; Carrington M; de Melo Neto OP
RNA Biol; 2015; 12(3):305-19. PubMed ID: 25826663
[TBL] [Abstract][Full Text] [Related]
12. Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A.
Cencic R; Robert F; Galicia-Vázquez G; Malina A; Ravindar K; Somaiah R; Pierre P; Tanaka J; Deslongchamps P; Pelletier J
Blood Cancer J; 2013 Jul; 3(7):e128. PubMed ID: 23872707
[TBL] [Abstract][Full Text] [Related]
13. The Expression Alteration of BC1 RNA and its Interaction with Eukaryotic Translation Initiation Factor eIF4A Post-Status Epilepticus.
Zeng X; Zong W; Gao Q; Chen S; Chen L; Zeng G; Huang W; Li Z; Zeng C; Xie Y; Li X; Xiao B; Dongsheng-Ouyang ; Hu K
Neurochem Res; 2018 Jul; 43(7):1328-1338. PubMed ID: 29774448
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI.
Zakowicz H; Yang HS; Stark C; Wlodawer A; Laronde-Leblanc N; Colburn NH
RNA; 2005 Mar; 11(3):261-74. PubMed ID: 15661843
[TBL] [Abstract][Full Text] [Related]
15. EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax.
Fooks K; Galicia-Vazquez G; Gife V; Schcolnik-Cabrera A; Nouhi Z; Poon WWL; Luo V; Rys RN; Aloyz R; Orthwein A; Johnson NA; Hulea L; Mercier FE
J Exp Clin Cancer Res; 2022 Dec; 41(1):340. PubMed ID: 36482393
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the conserved glutamate immediately following the DEAD box in eukaryotic translation initiation factor 4AI.
Patel K; Shah GK; Kommaraju SS; Low WK
Biochem Cell Biol; 2014 Feb; 92(1):33-42. PubMed ID: 24471916
[TBL] [Abstract][Full Text] [Related]
17. Interactions between eIF4AI and its accessory factors eIF4B and eIF4H.
Rozovsky N; Butterworth AC; Moore MJ
RNA; 2008 Oct; 14(10):2136-48. PubMed ID: 18719248
[TBL] [Abstract][Full Text] [Related]
18. VP1, the RNA-dependent RNA polymerase and genome-linked protein of infectious bursal disease virus, interacts with the carboxy-terminal domain of translational eukaryotic initiation factor 4AII.
Tacken MG; Thomas AA; Peeters BP; Rottier PJ; Boot HJ
Arch Virol; 2004 Nov; 149(11):2245-60. PubMed ID: 15503210
[TBL] [Abstract][Full Text] [Related]
19. Functional impairment of eIF4A and eIF4G factors correlates with inhibition of influenza virus mRNA translation.
Yángüez E; Castello A; Welnowska E; Carrasco L; Goodfellow I; Nieto A
Virology; 2011 Apr; 413(1):93-102. PubMed ID: 21377182
[TBL] [Abstract][Full Text] [Related]
20. eIF4F: a retrospective.
Merrick WC
J Biol Chem; 2015 Oct; 290(40):24091-9. PubMed ID: 26324716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
